Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$10.98 USD
-0.34 (-3.00%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $10.85 -0.13 (-1.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Lyell Immunopharma, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
LYEL 10.98 -0.34(-3.00%)
Will LYEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LYEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LYEL
Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why
After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
LYEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know
Other News for LYEL
12 Health Care Stocks Moving In Thursday's After-Market Session
Lyell Immunopharma (LYEL) Secures $100M Private Placement to Fund Clinical Milestones | LYEL ...
Lyell Immunopharma announces up to $100 million equity private placement
Lyell Immunopharma Announces up to $100 Million Equity Private Placement | LYEL Stock News
Lyell Immunopharma announces up to $100M equity private placement